Administration of aspirin and risk of pancreatic ductal adenocarcinoma
A recent study by Sanat et al. (2023) investigated Aspirin’s potential protective effects against Pancreatic Ductal Adenocarcinoma (PDAC), leveraging its antioxidant and anti-inflammatory properties1. This case-control study included 470 PDAC patients and 526 matched controls from Shariati Hospital...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pakistan Medical Association
2024-12-01
|
| Series: | Journal of the Pakistan Medical Association |
| Subjects: | |
| Online Access: | https://jpma.org.pk/index.php/public_html/article/view/20483 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|